CARDIOVASCULAR SAFETY IN THERAPY OF DIABETES MELLITUS TYPE 2
Diabe tes mellitus is chronical disease, lead to vascular complications. The safety of hypoglycemic therapy influences on cardiovascular complications. In this review results of some large-scale clinic trials directed to prevention of cardiovascular complications are provided.
Main Authors: | A. F. VERBOVOY, A. V. PASHENTSEVA, Y. A. DOLGIKH, A. S. OSINA, L. A. SHARONOVA |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Remedium Group LLC
2016-12-01
|
Series: | Медицинский совет |
Subjects: | |
Online Access: | https://www.med-sovet.pro/jour/article/view/1638 |
Similar Items
-
Imbalance in glycemic control between the treatment and placebo groups in cardiovascular outcome trials in type 2 diabetes
by: Rumiko Shimazawa, et al.
Published: (2019-12-01) -
Cardiovascular implications of modern algorithm of hypoglycemic therapy: ?Florentine hypothesis?
by: Andrey Alexeevich Aleksandrov, et al.
Published: (2010-12-01) -
Decreased Serum Dickkopf-1 Levels After Hypoglycemic Therapy in Patients with Type 2 Diabetes Mellitus
by: Gao F, et al.
Published: (2022-09-01) -
Insulin resistance in therapeutic clinic
by: Anna V. Pashentseva, et al.
Published: (2017-09-01) -
Insulin Fact Sheet in Type 1 and 2 Diabetes Mellitus and Trends of Antidiabetic Medication Use in Insulin Users with Type 2 Diabetes Mellitus: 2002 to 2019
by: Jiyun Park, et al.
Published: (2023-03-01)